Comorbilidad en la migraña: depresión, ansiedad, estrés y trastornos del sueño

Sevillano-García,; Manso-Calderón, Raquel; P, Cacabelos-Pérez

doi:10.33588/rn.4507.2007122

Cited by 14 publications

(6 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It was established that migraine is closely related to both depression and anxiety that coincides with the data obtained in other studies. 34,35 According to our results, patients after total lockdown demonstrated a significant decrease in the level of depression and an improvement in the quality of life, that may be related to a reduction in work pressure, as well as a possible improvement in sleep quality and eating habits. Our findings are consistent with the results of Parodi et al 36 that explain these findings with a reduction in the number of triggers as a result of decreased work and social activity.…”

Section: Discussionmentioning

confidence: 66%

The impact of the COVID-19 pandemic on patients with migraine

Hrytsenko

Kopchak

Kozyk³

et al. 2023

SAGE Open Medicine

View full text Add to dashboard Cite

Objectives: The aim of our work was to assess the impact of the COVID-19 pandemic and quarantine measures on migraine patients in regards to the activity of the disease, the psycho-emotional background of the patients and their quality of life. Methods: his study included 133 patients with established diagnosis of migraine. All study participants were divided into two clinical groups: A—patients with chronic and episodic forms of migraine, who had a history of positive PCR test for COVID-19, and B—patients with chronic and episodic forms of migraine who did not have a history of coronavirus disease. Results: We detected increase in the number of antimigraine medication ( p = 0.04), frequency of headache attacks ( p = 0.01), and the psycho-emotional state deterioration (increase in the Hamilton anxiety scale score) ( p = 0.002) in patients after recovery from the coronavirus disease. There was no significant difference in the headache’s intensity according to the VAS scale ( p = 0.51) as well as in the dynamics of the Beck depression scale score ( p = 0.09) before and after the COVID-19 infection. Conclusion: Patients with a history of migraine who recovered from COVID-19 showed increased frequency of migraine headache attacks and anxiety.

show abstract

Section: Discussionmentioning

confidence: 66%

The impact of the COVID-19 pandemic on patients with migraine

Hrytsenko

Kopchak

Kozyk³

et al. 2023

SAGE Open Medicine

View full text Add to dashboard Cite

show abstract

“…Insomnia and depression are related in a complex and bidirectional way. Both insomnia and depression may be the “common end of a path” or the expression of numerous and different but possibly concurrent etiologies, among which lifestyle and stressful situations play a significant role (Sevillano-García et al, 2007).…”

Section: Discussionmentioning

confidence: 99%

Salivary Interleukin 1-Beta Concentration Associates With Sleep Quality in Older Individuals

Valle

Ballestar-Tarín

Mafla-España

et al. 2023

Biological Research For Nursing

View full text Add to dashboard Cite

Background: Poor sleep quality is prevalent in older people and impairs their quality of life. Various studies show an association between sleep disorders and altered levels of inflammatory cytokines. The cytokine IL-1β has been shown to display both somnogenic and insomnia-promoting effects in experimental animals. Objectives: to evaluate the relationship between insomnia and salivary IL-1β concentration and the role of associated factors such as the symptoms of depression, use of hypnotics, intake of caffeinated beverages, smoking, and alcohol use in older individuals. An analytical, cross-sectional, observational research was carried out with a population of community-dwelling individuals over 60 years of age in Valencia (Spain). Sleep quality was measured with the Athens insomnia scale (AIS) and depressive symptoms with Geriatric Depression Scale (GDS). Results: 287 individuals participated in the study (mean age 74.08 years (76.7% women). 41.5% of the participants had insomnia, 36.9% took drugs for sleep problems, and 32.4% had relevant depressive symptoms. There was a significant inverse correlation between the IL-1β and total AIS score (rho = −0.302, p < 0.001), the sleep difficulty subdomain (rho = −0.259, p < 0.001), and the daytime sleepiness subdomain (rho = −0.322, p < 0.001). No significant correlation was observed between GDS and salivary IL-1β concentration. The IL-1β concentration was significantly lower in individuals taking drugs for sleeping compared with those not taking those drugs (1.11 ± 0.09 and 1.48 ± 0.08, respectively; p = 0.001). Regarding the AIS score, there was no significant difference in marital status, smoking, or the number of cups of tea or cola drinks, but there was a significant association with alcohol intake ( p = 0.019) and in the number of daily intakes of coffee ( p = 0.030). The receiver operating characteristic (ROC) curve analysis of IL-1β for diagnosis of moderate-severe insomnia showed an area under the curve (AUC) value of 0.78 (95% confidence interval 0.71–0.85). At the cut-off of 0.83 pg/µL of Il-1β, it had a sensitivity of 70.3% and a specificity of 69.8%.

show abstract

“…Furthermore, 50%-60% of patients with migraine were found to be anxious and/or depressed, and around 40% complained of sleep disturbance. 2,3 They had significantly higher levels of stress than controls. 4 In a 90-day prospective daily-diary cohort study involving adults with episodic migraine, increased levels of stress were associated with a migraine episode the following day.…”

Section: Introductionmentioning

confidence: 88%

Impact of SARS-CoV-2 Infection and Vaccination on Migraine Symptoms during the COVID-19 Pandemic

Silva,

Lopes,

Pontes

et al. 2024

Sinapse

View full text Add to dashboard Cite

Introduction: Studies have shown the worsening of migraine associated with the COVID-19 infection and the pandemic more broadly. COVID-19 vaccination has also been associated with symptomatic headache, with high frequency among migraineurs. We aimed to assess the impact of COVID-19 diagnosis and vaccine administration on migraine, during the SARS-CoV-2 pandemic. Methods: An online questionnaire was sent to migraine patients followed in a neurology outpatient clinic between March and November 2022. The survey inquired about migraine symptoms and treatment changes, as well as sleep changes, anxiety, and depressive symptoms during the pandemic, after a COVID-19 diagnosis and/or vaccination. Results: Out of the 185 patients included, 108 (58.4%) reported a change in headache pattern (intensity, frequency, and/or pain quality) and 47% reported higher intensity and frequency. The pattern changes occurred before the COVID-19 diagnosis in 41%. Of all the participants with headache changes 72.2% needed to intensify medication (abortive or prophylaxis), regardless of infection status. High levels of insomnia, anxiety, and depressive symptoms were found among patients with worsening migraine, irrespective of COVID-19 diagnosis. After vaccination, 49 (27.1%) described a change in headache pattern, with a worsening pattern in 29 (16%). In half, this change occurred for up to 3 weeks. Conclusion: Worsening of migraine was more likely associated with other factors related to the pandemic rather than COVID-19 diagnosis. COVID-19 vaccination might have acted as an additional but less relevant and temporary trigger for migraine worsening.

show abstract

Comorbilidad en la migraña: depresión, ansiedad, estrés y trastornos del sueño

Cited by 14 publications

References 0 publications

The impact of the COVID-19 pandemic on patients with migraine

The impact of the COVID-19 pandemic on patients with migraine

Salivary Interleukin 1-Beta Concentration Associates With Sleep Quality in Older Individuals

Impact of SARS-CoV-2 Infection and Vaccination on Migraine Symptoms during the COVID-19 Pandemic

Contact Info

Product

Resources

About